hillsbr1

Time to buy GILD. Dropped too far. Remesvidir

NASDAQ:GILD   Gilead Sciences, Inc.
Time to buy GILD. Remesvidir and recently bounced off a low resistance of approximately $61.

Remesvidir recently was said to reduce recovery time from Covid-19. More info: www.gilead.com/purpo...t-veklury-remdesivir
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.